Eduardo A. Peña Rojas

Author

Also Known As

E ROJAS, E Rojas, E. Rojas, Eduardo A Rojas, Eduardo A. Peña Rojas, Eduardo A. Rojas, Eduardo Andres Rojas, Eduardo Rojas, Ezequiel Lovera Rojas

Publications

674

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)McMaster University McMaster University Medical Centre

About

Eduardo A. Peña Rojas is an author at Pfizer (United States) specializing in medicine, immunology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	448
2	Immunology	4	4	362
3	Health Sciences	3	3	101
4	Microbiology	3	3	101
5	Cell Biology	1	1	253

Eduardo A. Peña Rojas

Publications

636

Citations

H-Index

Page 1

	Year	Citations
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment Sophie M. Poznanski, Kanwaldeep Singh, Tyrah M. Ritchie, Cell Metabolism Tumor BiologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2021	253
Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors Ana L. Portillo, Richard T. Hogg, Sophie M. Poznanski, iScience	2021	67
Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases Salvador Benlloch, José M. Galbis, Cristina Alenda, Annals of Oncology Cancer DetectionMolecular MarkersMedicinePathologyCancer Genomics	2008	55
Evaluation of Approaches to Monitor Staphylococcus aureus Virulence Factor Expression during Human Disease Wouter Rozemeijer, Pamela S. Fink, Eduardo A. Peña Rojas, PLoS ONE Pathogen DetectionMicrobial PathogensImmunologyStaphylococcus AureusBacterial Pathogens	2015	47
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, PLoS ONE	2019	44
Genetic stability of live, cold-adapted influenza virus components of the FluMist®/CAIV-T vaccine throughout the manufacturing process Deborah A. Buonagurio, Thomas M. Bechert, Chin‐Fen Yang, Vaccine VaccinationVaccine DevelopmentVaccine TargetImmunologyManufacturing Process	2005	39
Expanded human NK cells from lung cancer patients sensitize patients’ PDL1−negative tumors to PD1-blockade therapy Sophie M. Poznanski, Tyrah M. Ritchie, Isabella Y. Fan, Journal for ImmunoTherapy of Cancer	2021	36
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections C. Hal Jones, Naglaa Mohamed, Eduardo A. Peña Rojas, Journal of Clinical Microbiology Pathogen DetectionPathologyCapsule TypingCarriage Isolate CollectionsMedical Microbiology	2015	31
The early interferon response of nasal-associated lymphoid tissue to<i>Streptococcus pyogenes</i>infection Kendra A. Hyland, Robert Brennan, Stephen B. Olmsted, FEMS Immunology & Medical Microbiology	2009	28
Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines Eduardo A. Peña Rojas, J Meneses Hoyos, Neil J. Oldfield, PLoS ONE Pathogen DetectionRt-pcr AssaysImmunologyMedical MicrobiologyReverse Vaccinology	2015	23

Page 1